New antimicrobial agents active against Staphylococcus aureus
Clinical Trials Report
- Cite this article as:
- Tan, J.S. Curr Infect Dis Rep (2005) 7: 357. doi:10.1007/s11908-005-0009-x
- 23 Downloads
Clinical and microbiologic results of this study support, preliminarily, that telavancin is an effective antimicrobial agent for the treatment of infection due to MRSA.
© Current Science Inc. 2005